Rationale: Loss-of-function studies in cardiac myocytes (CMs) are currently limited by the need for appropriate conditional knockout alleles. The factors that regulate CM maturation are poorly understood. Previous studies on CM maturation have been confounded by heart dysfunction caused by whole organ gene inactivation.
D
uring mammalian heart development, cardiac myocyte (CM) phenotype changes dramatically between fetal, neonatal, and adult stages. 1 Fetal CMs are small, proliferative, and primarily produce energy through glycolysis. In contrast, adult CMs are much larger, terminally differentiated, and primarily produce energy through oxidative phosphorylation. The transition from fetal to adult phenotypes, referred to as CM maturation, occurs most rapidly in the perinatal period in the mouse between the end of gestation and about postnatal day 20 (P20). The mechanisms that govern CM maturation are poorly understood. Presently, maturation of stem cells or nonmyocytes directed to differentiate into CMs is a major hurdle impeding the use of these technologies for disease modeling or therapeutic cardiac regeneration. 1 Understanding the factors that regulate endogenous CM maturation would facilitate efforts to overcome this hurdle.
Among the most characteristic and latest developing hallmarks of adult CMs are transverse tubules (T-tubules), which start to form at ≈P10 in mouse and become fully mature at ≈P20.
2 T-tubules are tubular invaginations of the plasma membrane that penetrate deep within CMs and align with the Z-lines of sarcomeres. The junctional sarcoplasmic reticulum comes in close proximity to T-tubules at specialized membrane microdomains known as dyads, which mediate Ca 2+ -induced Ca 2+ release, and thereby couples CM electric activity to contraction. The cardiac action potential rapidly spreads along T-tubules, where depolarization activates the L-type Ca 2+ channel. The resulting small influx of Ca 2+ activates RYR2 (Ryanodine Receptor-2), the major cardiac intracellular Ca 2+ release channel located on the junctional sarcoplasmic reticulum (SR). Activated RYR2 releases a large amount of Ca 2+ , which induces sarcomere contraction. Thus, T-tubules facilitate coordinated Ca 2+ release within large adult CMs which could not be achieved through sequential, diffusion-mediated spread of the Ca 2+ transient. 3, 4 Although the physiological functions of T-tubules have been well characterized, the molecular machinery that induces the maturation and maintenance of T-tubules is largely unknown. Junctophilin-2 (JPH2), 5, 6 a structural protein that is specifically expressed in CMs, uses its N-terminal plasma membranebinding motifs and C-terminal SR transmembrane domain to tether T-tubule and SR membrane together to form dyads. 7 CM-specific knockdown of Jph2 in mouse caused dramatic remodeling and loss of T-tubules during postnatal development. 2, 8 This result was interpreted as evidence that JPH2 is a critical regulator of T-tubule maturation. 2, 8 However, JPH2 depletion in this mouse model also causes severe cardiomyopathy and heart failure. 2, 8 T-tubule disruption is present in hearts with cardiomyopathy and heart failure. 9, 10 Thus, cardiomyopathy and heart failure confound the interpretation of the Jph2 knockdown phenotype with regard to its role in T-tubule maturation.
The confounding effect of secondary changes caused by cardiac stress response in conventional genetic analyses is a common problem for studies of CM maturation and indeed for cardiac biology in general. Genetic knockouts that induce cardiac dysfunction and failure precipitate a host of indirect secondary effects, and dissecting direct effects of genetic manipulations from secondary effects can be problematic. In this study, we established a platform for quickly producing genetic mosaic knockouts which allow investigation of cellautonomous effects of gene knockout within the context of normally functioning myocardium. We deployed this platform to precisely characterize CM maturation factors without the interference of heart failure. We found that JPH2 is not required for overall T-tubule formation; rather, it helps to stabilize T-tubules in the face of cardiac dysfunction. We then use this platform and a candidate-based approach to identify novel T-tubule maturation factors. This platform will be useful for dissecting cell-autonomous genetic pathways that regulate postnatal CM maturation and function. 
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Novelty and Significance
What Is Known?
• Genetic knockout or knockdown is a critical research strategy, but the commonly used approach requires developing and obtaining a different genetically modified mouse line for each gene, which is a slow process.
• Genetic knockout in the cardiac myocyte (CM) compartment often causes cardiac dysfunction, which initiates a panoply of secondary effects that can obscure the direct, cell-autonomous effects of gene inactivation.
• Junctophilin-2 is implicated in development of transverse tubules (T-tubules), a hallmark of CM maturation because knockdown of junctophilin-2 using shRNAs causes heart failure and T-tubule disruption.
What New Information Does This Article Contribute?
• We developed a CM selective, Cas9/AAV9-mediated gene inactivation platform, named CRISPR/Cas9/AAV9-based somatic mutagenesis (CASAAV), that allows efficient inactivation of a gene without developing or acquiring a new mouse line for the gene of interest.
• On administration of different titers of adeno-associated virus constructs, both organ-wide and cell-autonomous effects of gene depletion can be studied, allowing dissection of direct cell-autonomous effects from the secondary effects because of cardiac dysfunction.
• Applying CASAAV approach to study T-tubule maturation, we found that junctophilin-2 plays a minor cell-autonomous role in T-tubule maturation, and we uncovered a novel, cell-autonomous role for RYR2 (Ryanodine Receptor-2) in T-tubule maturation.
CM-selective genetic loss of function is a powerful strategy for dissecting gene function in the heart. However, implementing this strategy using the traditional approaches is time-consuming, and results are vulnerable to misinterpretation because of secondary effects caused by organ-wide gene inactivation. Here, we show that a Cas9-based and adeno-associated virus-based platform (CASAAV) permits efficient and rapid gene inactivation, in either a small or large fraction of CMs. We deploy this new method to study T-tubule formation, a hallmark of mature CMs. Using the CASAAV platform, we show that junctophilin-2, a gene previously found to be essential for T-tubule maturation, has a limited role in this process. A CASAAV candidate-based screen uncovered an unanticipated role for RYR2 in T-tubule formation. The CASAAV platform and the mosaic gene inactivation strategy provide avenues to more rapidly and precisely perform in vivo genetic lossof-function studies in CMs.
Methods
Materials and Methods are available in the Online Data Supplement.
Adeno-Associated Virus
AAV-U6gRNA-cTNT-Cre plasmid (Online Figure I) was constructed by transferring a cTNT-Cre cassette from AAV-TNT-Cre plasmid 11 to PX552 plasmid. 12 A second U6gRNA was further added to generate AAV-U6gRNA 1 -U6gRNA 2 -cTNT-Cre (Addgene No. 87682). A total of 20 bp gRNA sequences (Online Table I ) were cloned into these plasmids through a single ligation step.
Adeno-associated virus (AAV) was produced and purified using a standard protocol with modifications. 13 AAV titer was quantified by quantitative polymerase chain reaction using primers indicated in Online Table II .
Mice
All animal procedures were approved by the Boston Children's Hospital Institutional Animal Care and Use Committee. AAVs were injected into P1 Rosa Cas9GFP/Cas9GFP mice 14 by subcutaneous injection. CMs were dissociated by retrograde collagenase perfusion as described previously.
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Validation and Examination of Jph2 Depletion in CMs
The mRNA level of Jph2 was examined by quantitative reverse transcription polymerase chain reaction (qRT-PCR) using primers shown in Online Table II . The deletion of Jph2 between 2 gRNAs was detected by RT-PCR. Construction of DNA libraries for amplicon sequencing was performed by modifying a published protocol 16 using primers shown in Online Table II . Paired-end, 250 bp reads were generated on an Illumina MiSeq and analyzed using CRISPResso software. 17 Validation of gene knockout was performed through immunofluorescence. Antibodies and dyes used are listed in Online Table III . Hearts were dissociated into single CMs through retrograde collagenase perfusion. Then, the CMs were briefly cultured to allow attachment to laminin-coated glass coverslips. Next, the CMs were fixed by 4% paraformaldehyde, and immunostaining was performed as described. 18, 19 Confocal images were taken using Olympus FV1000 inverted laser scanning confocal microscope equipped with a 60X/1.3 silicone oil objective.
Flow Cytometry
Quantitative analysis by flow cytometry was performed using a Propel Laboratories Avalon cytometer with a 100 µm nozzle and standard GFP/RFP (green/red fluorescence protein) filter sets. Data were further analyzed using BioRad ProSort software.
Fluorescence-activated cell sorting was performed using a BD AriaII SORP cell sorter with a 100 µm nozzle at Dana-Farber flow cytometry core facility.
Analyses of Heart Phenotypes
Gross heart morphology was imaged under a stereomicroscope (Zeiss SteREO Discovery V8) with an AxioCam MRc camera. Heart histology, organ weights, and expression of cardiac stress markers were assayed as described previously. 13 Echocardiography was performed on awake animals using a VisualSonics Vevo 2100 with Vevostrain software. Echocardiography was performed blinded to AAV types and doses.
T-Tubule Imaging and Analysis
In situ T-tubule imaging and AutoTT analysis of T-tubule patterns were performed as described previously.
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Intracellular Ca 2+ Recording
Intracellular Ca 2+ was measured in isolated CMs that were loaded with Rhod-2 AM (acetoxymethyl). Cells were electrically stimulated at 1 Hz to produce steady-state conditions. All image data were acquired in the line scanning mode along the long axis of the cell using an Olympus FV1000 inverted laser scanning confocal microscope with a 60X/1.3 silicone oil objective.
Statistics
Unless otherwise noted, values are displayed as mean±SD. Statistical comparisons were performed using Student t test. Kaplan-Meier survival analysis was performed using JMP software (SAS).
Results
CRISPR/Cas9/AAV9-Based Somatic Mutagenesis Efficiently Depletes JPH2 in CMs During CM Maturation
Previously our laboratory showed that the heart could tolerate the deletion of essential genes in a small fraction of CMs while still maintaining normal heart function. 11 This mosaic analysis allowed us to study CM maturation in individual cells without the interference of secondary effects caused by heart failure. To establish a versatile technical platform that allows mosaic somatic mutagenesis of any gene specifically in CMs, we combined AAV-mediated mosaic transduction 11 with CRISPR/Cas9-based in vivo mutagenesis.
14,21-24 We constructed AAV vectors that contain 1 or 2 U6 promoter-driven gRNA expression cassettes and a cardiac troponin-T promoter that drives CM-specific expression of Cre recombinase ( Figure 1A ; Online Figure I ). Using these vectors, we generated AAV9, 25 a cardiotropic AAV serotype, and subcutaneously injected the replication-deficient virus into Rosa26 mice that harbor a Cre-inducible Cas9-P2A-GFP allele. 14 cTNT-Cre activated the expression of Cas9 and GFP specifically in AAV-transduced CMs, and the U6 promoter drove expression of gRNA(s) in these cells ( Figure 1A) . Thus, GFP + CMs express Cas9 nuclease activity that is directed specifically to target sites by gRNA(s). The nuclease creates DNA double-strand breaks at these target sites and triggers DNA damage repair by nonhomologous end joining, which is error prone and frequently results in insertions or deletions that can induce frameshift mutations silencing the targeted genes ( Figure 1A ). 26 We first designed a gRNA that targets tdTomato gene and tested whether the tdTomato protein in Rosa Cas9-GFP/tdTomato mice is depleted by this CRISPR/Cas9/AAV9-based somatic mutagenesis (CASAAV) system. We injected AAV-TNT-Cre (negative control) or AAV-gRNA(tdTomato)-TNT-Cre into P1 littermate pups and isolated CMs at 1 month by retrograde collagenase perfusion. The CMs were analyzed by flow cytometry to detect GFP and tdTomato. We found that tdTomato was depleted in ≈89% GFP + CMs that were transduced by AAV expressing tdTomato gRNA ( Figure 1B) . No depletion was detected in GFP + CMs transduced with control AAV that lacked gRNA ( Figure 1B ; Online Figure  II) . Interestingly, although theoretically Cre should trigger expression of both Tomato and Cas9-P2A-GFP, we also detected tdTomato + GFP − cells (Online Figure II) . Two effects likely resulted in these cells: (1) some CMs transiently harbor AAV, and limited Cre exposure activates tdTomato but not Cas9-P2A-GFP, as a result of differential sensitivity of these alleles to Cre activation and (2) GFP level was observed to be sensitive to CM stress, as occurs during CM dissociation and flow cytometry. The net effect is that a minority of GFP − cells may have undergone Cas9 genome editing, a technical factor that needs to be considered when interpreting data (Discussion). Overall, this pilot experiment demonstrates that the CASAAV system mediates highly efficient gene silencing in CMs in vivo.
Next, we designed 2 gRNAs that target the coding sequence of Jph2 within exon 1, which encodes the first 4 plasma membrane-binding motifs of JPH2 protein ( Figure 1C ). These gRNAs had at least 3 mismatches to any nontargeted sequences in the mouse reference genome (Online Figure IIIA). We generated AAVs that expressed each gRNA individually (Jph2-gRNA1 or Jph2-gRNA2), or both simultaneously (Jph2-gRNA1+2), and injected 1.1×10 9 vg/g (viral genomes per gram body weight) AAV into P1 Rosa Cas9-GFP/ Cas9-GFP pups. We isolated CMs from P21 hearts and performed immunofluorescence to detect JPH2 protein ( Figure 1D ). We found that Jph2-gRNA1, Jph2-gRNA2, and Jph2-gRNA1+2 depleted JPH2 immunofluorescence in ≈55%, ≈70%, and ≈80% of GFP + CMs, respectively ( Figure 1E ). We also analyzed JPH2 depletion in transduced CMs by using fluorescence-activated cell sorting to purify GFP + CMs, followed by Western blot ( Figure 1F and 1G). Jph2-gRNA1+2 efficiently depleted JPH2 in transduced CMs. The level of BIN1, another protein implicated in T-tubule maturation, 27 was not affected ( Figure 1G ). The major effect of Jph2-gRNA1+2 was protein depletion rather than truncation (Online Figure IV) , although we cannot exclude production of truncated protein in a low fraction of transduced cells. Overall, our data show that Jph2-CASAAV efficiently depleted JPH2 in CMs and that 2 gRNAs were more efficient at achieving protein depletion than each single gRNA.
To determine the mechanisms that mediate this efficient JPH2 depletion, we injected 5.5×10
10 vg/g AAV at P1, which is sufficient to transduce ≈75% CMs in the heart (Figure 2 ). At P7, we extracted RNA from heart apexes and detected significantly decreased Jph2 mRNA after AAV-Jph2gRNA treatment by quantitative RT-PCR ( Figure 3A and 3B). Analysis of Jph2 transcript structure by RT-PCR demonstrated that dualgRNA CASAAV induced deletion of the intervening coding sequence between 2 gRNA targets in a subset of transcripts, which was not observed with either gRNA alone ( Figure 3A and 3C). To more precisely define the effect of CASAAV on Jph2 transcripts, we amplified each gRNA-targeted site from cDNA and performed next-generation sequencing (AmpliconSeq) 28 (Figures 2D through 2F and 3A; Online Figure IIIB and IIIC). Analysis of these sequences using CRISPResso 17 showed that gRNA1 alone generated mutations in 72% of transcripts, and 71% of these mutated reads shift the translational reading frame ( Figure 3D ). gRNA2 alone generated mutations in 61% of transcripts, and 86% of these mutated reads shift the translational reading frame ( Figure 3D ). These mutations localized to the expected gRNA cleavage sites ( Figure 3E ). When both gRNAs were present, frameshift mutations were detected in >80% mutated reads, and these mutations occurred between the 2 gRNA-targeted sites ( Figure 3D through 3F) . Thus, JPH2 protein depletion induced by CASAAV is because of a combination of frame-shifting mutations and mRNA decrease, potentially resulting from nonsense-mediated decay. 29 The use of 2 gRNAs increased the efficiency of both of these effects. Deletion of Jph2 coding sequences that encode critical plasma membrane-binding domains between the 2 gRNAtargeted sites also provides potential mechanisms to perturb the stability and function of JPH2 protein ( Figures 1C, 3C , and 3F).
AAV-Mediated Mosaic Infection Avoids Cardiomyopathies Caused by JPH2 Depletion
To determine the effect of AAV dosage on whole organ and individual CM phenotypes, we treated mice with serial dilutions of AAV-gRNA(Jph2)1+2-TNT-Cre, referred to subsequently as AAV-gRNA(Jph2), at P1. We defined the mice receiving 1.1×10 9 , 6.1×10 9 , 1.8×10 10 , and 5.5×10 10 vg/g AAV doses as Jph2_Low, Jph2_Mid, Jph2_High, and Jph2_Full groups, respectively. We measured the frequency of transduced CMs at P7 by detecting Cre-dependent GFP expression from the Rosa26 Cas9-GFP allele. AAV dose was positively correlated to the myocardial area occupied by GFP + CMs (Figure 2A) . We quantified the frequency of GFP + CMs in dissociated CM preparations. Jph2_Low, Jph2_Mid, Jph2_High, and Jph2_ Full groups expressed GFP in 22%, 47%, 64%, and 75% of CMs, respectively ( Figure 2B) .
Next, we investigated whether AAV dosage influences the efficiency of JPH2 depletion in individual transduced CMs. We performed immunofluorescence staining of JPH2 in CMs that were treated with different AAV doses at P1 and isolated at P7. The control AAV-TNT-Cre virus (lacking gRNA) was administered at the full dose (5.5×10 10 vg/g). Immunostaining of JPH2 was used to measure each cell's JPH2 expression level, and immunostaining of caveolin-3 (CAV3), a plasma membrane marker, defined the boundary of each single cell ( Figure 2C and 2D). We found a ≈70% decrease of JPH2 intensity in Jph2-CASAAV-treated CMs when compared with negative controls, which further confirmed the efficient depletion of JPH2 protein. By immunostaining, there was no detectable difference in intensity between GFP + CMs that were treated with different doses of AAVs ( Figure 2D ). To examine the impact of AAV dosage on the efficiency of protein depletion, we performed fluorescence-activated cell sorting of GFP + cells in each group and analyzed JPH2 expression by Western blotting ( Figure 2E ). This demonstrated efficient JPH2 depletion in all groups, although the protein remained detectable in the Jph2_Low and Jph2_Mid groups but was undetectable in the Jph2_High and Jph2_Full groups. Thus, AAV dose primarily determines the frequency of transduced CMs. The dose has a small effect on protein depletion efficiency among transduced cells, but even at the lowest dose tested, the protein was efficiently depleted. These findings are important for interpreting the mosaic gene knockout data presented below.
Mice that received the full dose of AAV-gRNA(Jph2) died between P10 and P13 ( Figure 4A ), which is consistent with the survival curve of Myh6-Cre;Jph2-shRNA mice described previously. 8 Mice treated with the other doses of AAV-gRNA(Jph2) survived beyond P20 ( Figure 4A ), when T-tubules become fully mature. 2 Because our goal was to examine the impact of Jph2 on T-tubule maturation, we focused the following studies on Jph2_Low, Jph2_Mid, and Jph2_High groups and studied mice at P21 to P24. Analyses of gross heart morphology showed that Jph2_High and Jph2_ Mid groups had cardiac hypertrophy and dilatation, which were not evident in the Jph2_Low group ( Figure 4B ). This difference was quantified by measurement of the heart weight/ body weight ratio, which was not elevated in the Jph2_Low group but was increased in Jph2_Mid and Jph2_High groups in a dose-dependent manner ( Figure 4C ). Echocardiography showed severely depressed heart systolic function in the Jph2_High group ( Figure 4D ). By contrast, the Jph2_Mid group had moderately depressed heart function, and the Jph2_Low group did not exhibit detectable heart dysfunction ( Figure 4D ). AAV-gRNA(Jph2) dosage also correlated with the extent of left ventricular dilatation ( Figure 4E and 4F) . Expression of cardiac stress markers Myh7, Nppa, and Nppb were consistent with these overall effects of virus dose on heart structure and functions ( Figure 4G ). Together, these data indicate that high and mid doses of AAV-gRNA(Jph2) caused dose-related cardiac hypertrophy and dysfunction, as previously reported in Jph2 shRNA genetic mouse models, 2,8 whereas the low dose did not impact heart function at the organ level.
We next examined the effect of the extent of Jph2 inactivation on the responses of individual CMs. Although induction of heart dysfunction correlated with increased CM size, there was no difference in CM size between GFP + and GFP − CMs at any viral dose ( Figure 4H ). Thus, JPH2 depletion does not directly affect CM size. Rather, JPH2 affects CM size indirectly through effects on overall organ function.
Collectively, these data show that a low dose of AAVgRNA(Jph2) can be used to achieve mosaic depletion of JPH2 without affecting overall organ function. Mid and high doses increase the fraction of CMs with gene inactivation and correspondingly cause organ dysfunction and global stress responses.
JPH2 Plays a Minor Role in T-Tubule Maturation
Because mosaic Jph2 inactivation by low-dose AAVgRNA(Jph2) avoided secondary effects of organ dysfunction, we were able to precisely examine the role of JPH2 in T-tubule organization without the confounding effects of cardiac dysfunction. To observe T-tubule organization in live CMs in intact heart ventricles, we labeled T-tubules with the plasma membrane dye FM 4 to 64 through retrograde heart perfusion and performed in situ confocal imaging. 2, 30 We found that T-tubules were dramatically disrupted in GFP + CMs in Jph2_High mice. However, this phenotype was mild in GFP + CMs in Jph2_Mid mice. No overt disruption in T-tubules was observed in GFP + CMs in Jph2_Low mice (Figure 5A and 5B; see additional representative confocal z stacks in Online Movies I through III). We analyzed the changes in T-tubules in details by performing unbiased quantification of T-tubule morphology using AutoTT software 20 ( Figure 5B ). This software objectively quantifies transverse T-tubule elements, transverse T-tubule elements and total T-tubule elements ( Figure 5C through 5F). The Jph2_Mid group also showed no significant change in longitudinal T-tubule elements, but a significant impairment in the other 3 parameters was greater than in the Jph2_Low group. All of these parameters were most dramatically impaired in the Jph2_High group. T-tubules in GFP − CMs from Jph2_High mice exhibited T-tubule defects, which were more severe than GFP + CMs in Jph2_Low and Jph2_Mid mice. These data are consistent with previous observations that T-tubules remodel and become disorganized in wild-type CMs in pathological conditions. 9 The GFP + CMs in Jph2_High mice had substantially more disrupted T-tubules than their GFP − counterparts ( Figure 5C through 5F), suggesting a cell-autonomous role for JPH2 to protect T-tubules from remodeling in heart failure. 31 We also examined the effect of JPH2 depletion on sarcomere structure, as assessed by immunostaining for Z-line marker sarcomeric α-actinin (Actn2; Online Figure V) . Z-line spacing and regularity, measured by AutoTT, 20 were not significantly affected by JPH2 depletion (Online Figure V) . Together these data demonstrate that JPH2 has a minor cell-autonomous function in T-tubule organization that is exacerbated by heart failure. To further confirm that these varied phenotypes were not caused by JPH2 depletion efficiency, we performed dual-color immunofluorescence to detect both JPH2 and CAV3 in CMs dissociated from AAV-TNT-Cre (control)-treated and AAVgRNA(Jph2)-treated mice. This permitted us to identify true JPH2-deficient CMs and examine CAV3 pattern in these CMs ( Figure 6A ). Consistent with in situ T-tubule imaging results, JPH2 − CMs that were derived from Jph2_Low mice exhibited normal global T-tubule morphology when compared with JPH2 + control CMs ( Figure 6A ). By contrast, Jph2_Mid and Jph2_High mice exhibited disrupted CAV3 patterns in JPH2 − CMs ( Figure 6A ). AutoTT quantification of CAV3 immunostaining also showed significantly decreased total T-tubule elements and regularity in JPH2 − CMs isolated from Jph2_Mid and Jph2_High mice, but no statistically significant difference between Jph2_Low and control was observed ( Figure 6B and 
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). It is possible that this experiment did not reproduce the mild T-tubule defects in Jph2_Low that were observed by in situ T-tubule imaging ( Figure 5 ) because the CM dissociation procedure affects T-tubule organization in some CMs and thereby increases within-group variation (compare error bars between Figure 5 and Figure 6 ). However, based on both in situ T-tubule analysis and CAV3 analysis on isolated CMs, it is clear that JPH2 has a minor direct function in T-tubule maturation. Substantial T-tubule disruption was only observed when JPH2 was depleted in a large fraction of CMs, resulting in cardiac stress and associated secondary effects on CMs ( Figure 6D ). We next evaluated whether the varied effect of JPH2 depletion on T-tubule organization influences Ca 2+ handling.
Freshly dissociated CMs were loaded with the Ca 2+ -sensitive dye Rhod-2 AM, and Ca 2+ transients were measured by confocal line scan imaging. Both transduced and nontransduced Jph2_High CMs exhibited significantly reduced Ca 2+ transient amplitude, prolonged time to peak, and slower time to 50% decay ( Figure 7A and 7B) , which is consistent with previous studies of JPH2's role in Ca 2+ handling. 2 However, the major effect was likely secondary to heart failure and not directly attributable to JPH2 depletion because the difference with TNT-Cre control and Jph2_High CMs was greater than the difference between GFP + and GFP − CMs within Jph2_High. Ca 2+ transient amplitude was more severely depressed in GFP + than GFP − Jph2_High CMs, consistent with the more severe T-tubule abnormalities observed in GFP + versus GFP − Jph2_High CMs. Jph2_Low GFP + CMs had Ca 2+ transients with mildly but significantly reduced peak amplitude compared with GFP − CMs isolated from the same heart. No significant change in time to peak or time to 50% decay was detected ( Figure 7C and 7D) . This is consistent with the minor effect of JPH2 depletion on T-tubule morphology in Jph2_Low. These single-cell measurements of Ca 2+ handling paralleled our imaging data on T-tubule structure and indicate that JPH2 has a minor cell-autonomous role in establishing Ca 2+ release unit function.
CASAAV-Based Screen Identifies RYR2 as a Novel T-Tubule Regulator
Mosaic mutagenesis by CASAAV avoids the time-consuming procedure of generating genetically modified mice. A large number of AAVs that deliver gRNAs directed at different genes can be generated side by side simultaneously. Thus, this technology allowed us to perform a genetic screen for novel T-tubule regulators. Using a candidate-based approach, we generated AAVs targeting 8 genes that could be potentially important for T-tubule maturation. These genes encode important cardiac transcriptional factors (NKX2-5 Cas9-P2A-GFP mice at a low dose (similar to that used in Jph2_Low), dissociated the hearts at P21, and performed JPH2 immunostaining to image T-tubule morphology in GFP + CMs ( Figure 8A ). GFP − CMs from the same heart were used as internal negative controls. Efficient depletion of NKX2-5, TEAD1, RYR2, and CAV3 was validated by immunostaining (Online Figure  VI ; Figure 8C and 8D).
Through this screen, we found that RYR2 depletion caused dramatic disruption of the JPH2 staining pattern ( Figure 8A and 8B). By contrast, the AAVs targeting the other 7 genes did not show this effect. Efficient depletion of RYR2 was observed in ≈65% of the AAV-infected GFP + CMs ( Figure 8C and 8D). Mice with mosaic RYR2 depletion in a minority of CMs (only ≈10% of total CMs were depleted of RYR2) maintained normal heart function ( Figure 8E ). Dramatic T-tubule disruption was − isolated CMs. In all images, scale bar=20 μm. Violin plots in G and I are as in Figure 2D . CMs were from 3 hearts. Student t test: *P<0.05; **P<0.01; ***P<0.001. Column charts show mean±SD. LE indicates longitudinal element; TE, transverse element; Total TT element=TE+LE; and TNT, troponin-T.
Discussion
In this study, we combined AAV-mediated mosaic transduction and CRISPR/Cas9-based somatic mutagenesis to establish a powerful technical platform, named CASAAV, which permits facile interrogation of cell-autonomous gene function in the postnatal heart. We also demonstrate the value of a genetic mosaic strategy to disentangle direct, cell-autonomous roles of a gene from changes that arise from effects on overall organ function. We anticipate that this strategy will allow the rapid and precise interrogation of gene function in the postnatal heart in diverse processes such as CM maturation, regeneration, and hypertrophy.
Somatic cardiac mutagenesis using a Cre-activated Myh6-Cas9 allele was described previously. 24 Our study used the more widely available Rosa26
Cas9-GFP mouse line, 14 which retains CM-selective gene inactivation in the heart because of the cardiotropic properties of AAV9 and cTNT-Cre-driven Cas9 activation. More importantly, our study focused on mosaic analysis of cell-autonomous phenotypes as a strength of the Cas9 somatic mutagenesis strategy. We performed foundational experiments that are required to fully exploit this strategy, including the demonstration that the dose of AAV mainly affects the frequency of transduced CMs but has only a small effect on the efficiency of gene inactivation among those CMs that are transduced. Furthermore, we provide data on the overall knockout efficiency of the system, demonstrate that tandem gRNAs targeting the same gene enhances knockout efficiency, and reveal the combination of mechanisms that collectively ensure a high knockout efficiency.
We combined CASAAV with in situ T-tubule imaging to study the genetic regulation of CM maturation in vivo. At a full virus dose to maximize the transduction of CMs, CASAAV fully recapitulated observations made using more traditional genetic models. For example, when JPH2 was depleted in a large fraction of CMs (Jph2_High and Jph2_Full), the heart exhibited ventricular dilatation, CM hypertrophy, and heart failure, which were all consistent with previous studies of Mhy6-Cre; Jph2-shRNA mice. 2, 8 Dramatic T-tubule defects and Ca 2+ transient abnormalities in Jph2_High mice also agreed with previous reports showing that organ-wide JPH2 knockdown caused heart failure and disrupted T-tubule organization and Ca 2+ handling. 2, 8 Thus, this technology can faithfully detect the function of a given gene at both organ and single-cell levels, which provides an alternative and more rapid means to study the function of a given gene in the heart, compared with generation of transgenic or knockout mice. A particular strength of the CASAAV system is the ability to rapidly generate genetic mosaics, which permits precise delineation of gene function that is difficult to achieve using constitutive or even inducible knockout models. For example, because JPH2 depletion caused early-onset heart failure, which itself is associated with T-tubule disruption, studies in traditional JPH2 knockout mice were unable to disentangle the direct role of JPH2 on T-tubule maturation from its role to stabilize T-tubules in the face of cardiac dysfunction. By using a low dose of AAV to direct JPH2 depletion, we were able to separate the function of JPH2 in T-tubule maturation from its requirement to stabilize T-tubules in heart failure. In CMs from Jph2_Low mice that lacked JPH2 but had overall preserved heart function, we observed very mild T-tubule defects. However, as we increased the fraction of CMs that lack JPH2, we observed worsening T-tubule defects in both transduced and nontransduced CMs that paralleled the extent of heart dysfunction. These observations are consistent with previous studies 2, 31 and suggest that widespread JPH2 depletion primarily affects T-tubule organization by impairing heart function. In failing hearts, we did observe that JPH2-depleted CMs had more severe T-tubule disruption than JPH2-replete CMs, supporting a role for JPH2 to stabilize T-tubules in the face of CM stress caused by heart dysfunction, as previously reported. 31 However, contrary to previous studies of JPH2 depletion done in the context of heart dysfunction, 2,8 our genetic mosaic approach shows that JPH2 has a minor cell-autonomous role in T-tubule maturation. This role of JPH2 was mirrored in its modest but measurable effects on Ca 2+ transient amplitude, which suggests that JPH2 may regulate RYR2 activation within Ca 2+ release units. A broader implication of these results is that studies of CM maturation or function need to use strategies such as genetic mosaicism to distinguish direct cellautonomous gene function from effects of gene inactivation that occur secondary to organ function impairment.
Another advantage of performing mosaic mutagenesis is that it permits study of genes that are essential for animal survival. For example, because RYR2 is the core Ca 2+ channel that directly drives heart contraction, RYR2 knockout rapidly causes embryonic death, 32 precluding its detailed functional analysis in vivo in the postnatal heart. By contrast, through AAV-based mosaic knockout, we were able to study the in vivo function of RYR2 in adult CMs while maintaining normal heart function. This provided us with the unprecedented opportunity to identify a novel role of RYR2 in T-tubule organization. Thus, the CASAAV platform opens the door to precisely investigate the cellular functions of essential genes in vivo, which otherwise would be technically inaccessible.
Our in vivo screen identified RYR2 as a previously undescribed regulator of T-tubule maturation. Further experiments will be required to define how RYR2 regulates T-tubule maturation. One possibility is that RYR2, located on junctional SR, serves a structural role by providing a scaffold that interacts with proteins on T-tubules. Another possibility is that normal Ca 2+ oscillations conducted through RYR2 are required to promote formation and maturation of T-tubules.
Because CRISPR/Cas9 provides the versatility to target most genes in the genome and CASAAV avoids the time and resources required to generate genetically modified mice, this technology greatly expedites the use of genetic loss-of-function strategies to study gene function in the postnatal heart. In our hands, the whole procedure from gene selection to phenotypic characterization of T-tubules in knockout CM can be done within 6 weeks. As a result, we were able to perform the in vivo screen that led to identification of RYR2 as a novel T-tubule regulator. Thus, this technology is well suited for in vivo genetic screening for regulators of CM phenotypes, such as maturation and hypertrophy.
Adenoviral and AAV-mediated delivery of short hairpin RNAs (shRNAs) have been previously used to knockdown genes in postnatal CMs. Compared with short hairpin RNAs, CASAAV has clear advantages. ShRNAs are unable to achieve complete protein depletion, and >70% depletion is often considered successful knockdown. ShRNAs must actively bind to target transcripts, so that knockdown depends on continued shRNA expression at sufficient levels compared with the endogenous transcript. With CASAAV, a subset of cells with homozygous truncating mutations will have complete protein depletion. Furthermore, CASAAV irreversibly modifies the genome, which makes gene knockdown irreversible, more potent than shRNAs, and likely accounts for the relative insensitivity of gene depletion efficiency among transduced cells to overall viral dose, a critical feature for the mosaic strategy.
The CASAAV system has some limitations. First, we are unaware of efficient homology-directed repair in terminally differentiated cells, making targeted knockin mutations infeasible. Second, as with RNA interference-based knockdown strategies, one should be cognizant of potential off-target activity and control for this possibility by careful gRNA design and, optimally, use of ≥2 independent gRNA pairs to target the same gene. Third, the possibility of gain-of-function mutations should be considered, for example, if the gRNA leads to C-terminal truncation and a dominant negative N-terminal protein fragment. We used gRNAs targeting near the N terminus of genes to minimize this possibility. Fourth, for the mosaic strategy to be successful, one needs means to identify individual cells that have undergone gene inactivation. Immunostaining with a high-quality antibody is one such assay. Alternatively, if the fraction of cells that have undergone gene depletion is sufficiently high, one can use GFP from Rosa26
Cas9-GFP as a surrogate marker. When doing so, one should also be aware that a low fraction of GFP-negative cells also could have undergone Cas9 mutagenesis but have lost GFP expression. Typically, this can be overcome by studying a large number of single cells.
In summary, we have developed a rapid and powerful technical platform for gene inactivation in postnatal CMs. This platform is particularly well suited for genetic mosaic analysis of genes to define the cell-autonomous functions. In the future, we anticipate that the capabilities of this system will be further extended by pairing it with single-cell functional phenotyping and single-cell RNA-seq.
